Sungpil Cho - Search Results

Year	Number of Results
2004	2
2007	1
2009	2
2010	2
2011	1
2012	1
2013	3
2014	1
2015	7
2017	3
2018	5
2019	1
2020	1
2021	3
2022	1
2023	1
2024	0

1

Oral Vaccine Delivery for Intestinal Immunity-Biological Basis, Barriers, Delivery System, and M Cell Targeting.

Kang SH, Hong SJ, Lee YK, Cho S. Kang SH, et al. Among authors: cho s. Polymers (Basel). 2018 Aug 27;10(9):948. doi: 10.3390/polym10090948. Polymers (Basel). 2018. PMID: 30960873 Free PMC article. Review.

2

Plasmid DNA Nanoparticles for Nonviral Oral Gene Therapy.

Shahriar SMS, An JM, Hasan MN, Surwase SS, Kim YC, Lee DY, Cho S, Lee YK. Shahriar SMS, et al. Among authors: cho s. Nano Lett. 2021 Jun 9;21(11):4666-4675. doi: 10.1021/acs.nanolett.1c00832. Epub 2021 May 24. Nano Lett. 2021. PMID: 34029475

3

Simply structured polarization-independent high efficiency multilayer dielectric gratings.

Cho HJ, Kim SJ, Kim KD, Cho SP, Tak IS, Kim GH, Moon BJ, Kim DH, Lee YS, Kim SI, Kim HT, Cho J. Cho HJ, et al. Appl Opt. 2022 Oct 1;61(28):8446-8453. doi: 10.1364/AO.469253. Appl Opt. 2022. PMID: 36256159

4

Oral siRNA Delivery to Treat Colorectal Liver Metastases.

Kang SH, Revuri V, Lee SJ, Cho S, Park IK, Cho KJ, Bae WK, Lee YK. Kang SH, et al. Among authors: cho s. ACS Nano. 2017 Oct 24;11(10):10417-10429. doi: 10.1021/acsnano.7b05547. Epub 2017 Oct 13. ACS Nano. 2017. PMID: 28902489

5

Fulvestrant alleviates cisplatin-induced acute kidney injury via repression of BNIP3-mediated apoptosis and autophagy.

Lee HJ, Kim YJ, Kim KH, Cho SP, Hong GL, Jung JY. Lee HJ, et al. J Pharm Pharmacol. 2023 Nov 6:rgad094. doi: 10.1093/jpp/rgad094. Online ahead of print. J Pharm Pharmacol. 2023. PMID: 37942668

6

Oral Delivery of Parathyroid Hormone Using a Triple-Padlock Nanocarrier for Osteoporosis via an Enterohepatic Circulation Pathway.

An JM, Shahriar SMS, Hwang YH, Hwang SR, Lee DY, Cho S, Lee YK. An JM, et al. Among authors: cho s. ACS Appl Mater Interfaces. 2021 May 26;13(20):23314-23327. doi: 10.1021/acsami.0c22170. Epub 2021 Feb 15. ACS Appl Mater Interfaces. 2021. PMID: 33587600

7

Antibody-mediated oral delivery of therapeutic DNA for type 2 diabetes mellitus.

Cha S, Lee SH, Kang SH, Hasan MN, Kim YJ, Cho S, Lee YK. Cha S, et al. Among authors: cho s. Biomater Res. 2018 Jul 27;22:19. doi: 10.1186/s40824-018-0129-7. eCollection 2018. Biomater Res. 2018. PMID: 30065848 Free PMC article.

8

Oral GLP1 Gene Delivery by an Antibody-Guided Nanomaterial to Treat Type 2 Diabetes Mellitus.

Hasan MN, Hwang YH, An JM, Shahriar SMS, Cho S, Lee YK. Hasan MN, et al. Among authors: cho s. ACS Appl Mater Interfaces. 2020 Sep 2;12(35):38925-38935. doi: 10.1021/acsami.0c09814. Epub 2020 Aug 19. ACS Appl Mater Interfaces. 2020. PMID: 32805914

9

Carboxymethyl Cellulose, Pluronic, and Pullulan-Based Compositions Efficiently Enhance Antiadhesion and Tissue Regeneration Properties without Using Any Drug Molecules.

An JM, Shahriar SMS, Hasan MN, Cho S, Lee YK. An JM, et al. Among authors: cho s. ACS Appl Mater Interfaces. 2021 Apr 14;13(14):15992-16006. doi: 10.1021/acsami.0c21938. Epub 2021 Apr 2. ACS Appl Mater Interfaces. 2021. PMID: 33797224

10

Oral siRNA delivery using dual transporting systems to efficiently treat colorectal liver metastasis.

Hyun EJ, Hasan MN, Kang SH, Cho S, Lee YK. Hyun EJ, et al. Among authors: cho s. Int J Pharm. 2019 Jan 30;555:250-258. doi: 10.1016/j.ijpharm.2018.11.009. Epub 2018 Nov 3. Int J Pharm. 2019. PMID: 30399434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

33 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year